First Bank & Trust
- SEC CIK
- 0001692632
- Latest filing
- Jul 9, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by First Bank & Trust, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q2 2026)
- 7,680
- Value
- $694.7K
- % of portfolio
- 0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 7,680 | $694.7K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 7,680 | $615.0K | 0.1% | +1,865+32.1% | Added | Holders |
| Q4 2025 | 5,815 | $495.7K | 0.1% | −280−4.6% | Reduced | Holders |
| Q3 2025 | 6,095 | $474.0K | 0.1% | −320−5.0% | Reduced | Holders |
| Q2 2025 | 6,415 | $501.7K | 0.1% | +82+1.3% | Added | Holders |
| Q1 2025 | 6,333 | $459.0K | 0.1% | +219+3.6% | Added | Holders |
| Q4 2024 | 6,114 | $452.6K | 0.1% | −5,977−49.4% | Reduced | Holders |
| Q3 2024 | 12,091 | $797.9K | 0.2% | −9,845−44.9% | Reduced | Holders |
| Q2 2024 | 21,936 | $2.03M | 0.4% | +956+4.6% | Added | Holders |
| Q1 2024 | 20,980 | $2.00M | 0.4% | +490+2.4% | Added | Holders |
| Q4 2023 | 20,490 | $1.56M | 0.4% | −3,108−13.2% | Reduced | Holders |
| Q3 2023 | 23,598 | $1.63M | 0.4% | −55−0.2% | Reduced | Holders |
| Q2 2023 | 23,653 | $2.23M | 0.6% | +1,288+5.8% | Added | Holders |
| Q1 2023 | 22,365 | $1.85M | 0.5% | +3,750+20.1% | Added | Holders |
| Q4 2022 | 18,615 | $1.39M | 0.4% | −3,481−15.8% | Reduced | Holders |
| Q3 2022 | 22,096 | $1.83M | 0.7% | +2,200+11.1% | Added | Holders |
| Q2 2022 | 19,896 | $1.89M | 0.6% | +3,711+22.9% | Added | Holders |
| Q1 2022 | 16,185 | $1.91M | 0.6% | +1,820+12.7% | Added | Holders |
| Q4 2021 | 14,365 | $1.86M | 0.8% | +280+2.0% | Added | Holders |
| Q3 2021 | 14,085 | $1.59M | 0.7% | +24+0.2% | Added | Holders |
| Q2 2021 | 14,061 | $1.46M | 0.7% | −259−1.8% | Reduced | Holders |
| Q1 2021 | 14,320 | $1.20M | 0.6% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.